Continuing Education Credits to be Provided to Professionals on Cannabidiol (CBD)-Rich Hemp Oil at Orlando Anti-Aging Medicine Conference
SAN DIEGO, May 16, 2014 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that its portfolio company, HempMeds™, is exhibiting at the American Academy of Anti-Aging Medicine (A4M) Orlando World Congress May 16-17. A continuing medical education (CME) course on cannabidiol (CBD) will be offered by a licensed Medical Doctor to over 2,500 medical and wellness industry professionals during the conference. The American Academy of Anti-Aging Medicine (A4M) promotes HempMeds™ as a Platinum Elite Sponsor on both the A4M and Worldhealth.net websites. The A4M is a 501(c) 3 non-profit organization with more than 26,000 members including physicians, scientists, and governmental officials from more than 120 nations.
During The A4M‘s Orlando conference on Friday, May 16th, Dr. John Hicks III will participate in a panel discussion on CBD’s reappearance in the medical field. Attendees may earn continuing education credits while learning about the emerging research on CBD, the endocannabinoid system, and other related topics. Dr. Hicks is presenting in the Product Theater at noon and HempMeds has sponsored the A4M Commercial Workshop, “Everything You Wanted to Know about Cannabidiol, but Were Afraid to Ask”at 6:45pm with the presentation by Dr. Hicks.
“Hemp has been around since the beginning of mankind and yet, due to propaganda that began at the turn of the last century, it was once banned from many countries,” says Charles Vest, VP of Communications for HempMeds™. “We are extremely excited for the opportunity to sponsor the professional education of leaders in the anti-aging field as this amazing, non-GMO plant makes a resurgence globally.”
Vest continues, “We would like to thank the A4M for the ability to have a world-renowned guest speaker present this fascinating topic and are looking forward to the resulting heightened awareness of CBD-rich hemp oil as a result of HempMeds’ participation in the A4M Orlando conference.”
The A4M is dedicated to the advancement of technology to detect, prevent, and treat aging-related disease, and to promote research into methods to slow and optimize the human aging process. The A4M website reports the global anti-aging market to be estimated at $292 billion by 2015. The organization further estimates that the anti-aging market represents 10% of the world’s population who are aged 60+ today, a figure that is projected to increase to 22% by 2050 as the “baby boomer” generation ages. Attendees at the conference that are interested in learning more about HempMeds can find the team at booth 305.
HempMeds’™ “DON’T MOVE” ad campaign will be featured at the conference’s “Product Theater” to help counter mainstream media reports that CBD oil is only available in Colorado. For more information on CBD-rich hemp oil products, please visit:
HempMeds offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor for Medical Marijuana Inc. In addition to handling sales and distribution, HempMeds is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact:
Investor relations contact:
Medical Marijuana, Inc.